SM
Suresh Mandhana
About Suresh Mandhana
Data last updated:
Suresh Mandhana is a Director at A-Mark Pharma Private Limited (since 2022), Director at Chemserves Pharma Private Limited (since 2017) and Additional Director at Relichem Pharma Private Limited (since 2015). The companies operate in Pharma and Consumer Goods. The 3 current companies with reported revenue have a combined latest revenue of ₹5.85 Cr; the largest is A-Mark Pharma Private Limited at ₹5.25 Cr (FY 2025). Earlier, Suresh Mandhana was a Director at Waxsen Lifescience Private Limited (from 2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Jan 2022 | 2011 | ₹5.25 Cr (FY 2025) | Active | |
| Director | 16 Feb 2017 | 2009 | ₹59.7 Lakh (FY 2019) | Active | |
| Additional Director | 27 Feb 2015 | 2012 | ₹13,846 (FY 2019) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Feb 2014 | 2009 | ₹8.64 Cr (FY 2019) | Under Cirp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Suresh Mandhana
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shilpi Mandhana | 03131387 | A-Mark Pharma Private Limited | Director |
| Rajendrakumar Satyanarayan Holani | 01182657 | Chemserves Pharma Private Limited , Relichem Pharma Private Limited | Additional Director |
| Rohitash Kailashchand Mandhana | 02479750 | Chemserves Pharma Private Limited , Relichem Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suresh Mandhana
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suresh Mandhana
Suresh Mandhana currently holds 3 directorships: A-Mark Pharma Private Limited (Director, since 25 Jan 2022, revenue ₹5.25 Cr (FY 2025)); Chemserves Pharma Private Limited (Director, since 16 Feb 2017, revenue ₹59.7 Lakh (FY 2019)); Relichem Pharma Private Limited (Additional Director, since 27 Feb 2015, revenue ₹13,846 (FY 2019)).
Suresh Mandhana was first appointed on 17 Feb 2014 as Director at Waxsen Lifescience Private Limited. The most recent appointment on record is 25 Jan 2022 at A-Mark Pharma Private Limited.
The 3 current companies of Suresh Mandhana that report revenue have a combined latest revenue of ₹5.85 Cr: A-Mark Pharma Private Limited ₹5.25 Cr (FY 2025); Chemserves Pharma Private Limited ₹59.7 Lakh (FY 2019); Relichem Pharma Private Limited ₹13,846 (FY 2019).
Suresh Mandhana held 1 earlier board appointment: Waxsen Lifescience Private Limited (Director, from 17 Feb 2014).
The current boards of Suresh Mandhana's companies include Shilpi Mandhana (A-Mark Pharma Private Limited), Rajendrakumar Satyanarayan Holani (Chemserves Pharma Private Limited), Rohitash Kailashchand Mandhana (Chemserves Pharma Private Limited).